Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

845 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions.
Sflomos G, Schipper K, Koorman T, Fitzpatrick A, Oesterreich S, Lee AV, Jonkers J, Brunton VG, Christgen M, Isacke C, Derksen PWB, Brisken C. Sflomos G, et al. Among authors: fitzpatrick a. Cancers (Basel). 2021 Oct 27;13(21):5396. doi: 10.3390/cancers13215396. Cancers (Basel). 2021. PMID: 34771558 Free PMC article. Review.
Assessing CSF ctDNA to Improve Diagnostic Accuracy and Therapeutic Monitoring in Breast Cancer Leptomeningeal Metastasis.
Fitzpatrick A, Iravani M, Mills A, Childs L, Alaguthurai T, Clifford A, Garcia-Murillas I, Van Laere S, Dirix L, Harries M, Okines A, Turner NC, Haider S, Tutt ANJ, Isacke CM. Fitzpatrick A, et al. Clin Cancer Res. 2022 Mar 15;28(6):1180-1191. doi: 10.1158/1078-0432.CCR-21-3017. Clin Cancer Res. 2022. PMID: 34921020 Free PMC article.
Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer.
Rätze MAK, Koorman T, Sijnesael T, Bassey-Archibong B, van de Ven R, Enserink L, Visser D, Jaksani S, Viciano I, Bakker ERM, Richard F, Tutt A, O'Leary L, Fitzpatrick A, Roca-Cusachs P, van Diest PJ, Desmedt C, Daniel JM, Isacke CM, Derksen PWB. Rätze MAK, et al. Among authors: fitzpatrick a. Oncogene. 2022 May;41(21):2932-2944. doi: 10.1038/s41388-022-02314-w. Epub 2022 Apr 18. Oncogene. 2022. PMID: 35437308 Free PMC article.
Correction: Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer.
Rätze MAK, Koorman T, Sijnesael T, Bassey-Archibong B, van de Ven R, Enserink L, Visser D, Jaksani S, Viciano I, Bakker ERM, Richard F, Tutt A, O'Leary L, Fitzpatrick A, Roca-Cusachs P, van Diest PJ, Desmedt C, Daniel JM, Isacke CM, Derksen PWB. Rätze MAK, et al. Among authors: fitzpatrick a. Oncogene. 2022 Jun;41(26):3507-3509. doi: 10.1038/s41388-022-02355-1. Oncogene. 2022. PMID: 35610485 Free PMC article. No abstract available.
Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma.
Böhm S, Montfort A, Pearce OM, Topping J, Chakravarty P, Everitt GL, Clear A, McDermott JR, Ennis D, Dowe T, Fitzpatrick A, Brockbank EC, Lawrence AC, Jeyarajah A, Faruqi AZ, McNeish IA, Singh N, Lockley M, Balkwill FR. Böhm S, et al. Among authors: fitzpatrick a. Clin Cancer Res. 2016 Jun 15;22(12):3025-36. doi: 10.1158/1078-0432.CCR-15-2657. Clin Cancer Res. 2016. PMID: 27306793 Free article.
Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma.
Böhm S, Faruqi A, Said I, Lockley M, Brockbank E, Jeyarajah A, Fitzpatrick A, Ennis D, Dowe T, Santos JL, Cook LS, Tinker AV, Le ND, Gilks CB, Singh N. Böhm S, et al. Among authors: fitzpatrick a. J Clin Oncol. 2015 Aug 1;33(22):2457-63. doi: 10.1200/JCO.2014.60.5212. Epub 2015 Jun 29. J Clin Oncol. 2015. PMID: 26124480
Nitric oxide induces human CLA+CD25+Foxp3+ regulatory T cells with skin-homing potential.
Yu C, Fitzpatrick A, Cong D, Yao C, Yoo J, Turnbull A, Schwarze J, Norval M, Howie SEM, Weller RB, Astier AL. Yu C, et al. Among authors: fitzpatrick a. J Allergy Clin Immunol. 2017 Nov;140(5):1441-1444.e6. doi: 10.1016/j.jaci.2017.05.023. Epub 2017 Jun 7. J Allergy Clin Immunol. 2017. PMID: 28601680 Clinical Trial. No abstract available.
845 results